Clinical & Trials
Bayesian Trial Design
In one line
Trial design that uses Bayesian statistics, often incorporating prior data from related studies or registries.
Definition
Bayesian methods enable formal use of prior information (e.g., from pediatric extrapolation, OUS data, or historical controls) and continuous learning. Frequently used in device pivotal trials with limited recruitable populations.
FDA's 2010 guidance on Bayesian statistics in medical device clinical trials describes how priors can be used. Sponsors must justify the prior, show operating characteristics through simulation, and agree the design with FDA in advance. Methods like power priors or hierarchical models discount prior information when it conflicts with new data.
Why it matters
FDA's CDRH has decades of experience with Bayesian device approvals; the agency publishes specific Bayesian guidance for medical devices.
Common pitfalls
- •One common pitfall is using overly optimistic prior distributions that are not adequately supported by historical data or clinical rationale, leading to skewed results.
- •Another mistake is failing to conduct thorough sensitivity analyses to understand the impact of different prior assumptions on the trial's conclusions.
- •Inadequate justification for the choice of prior information can lead to regulatory scrutiny and rejection of trial results.
- •Misinterpreting Bayesian credible intervals as frequentist confidence intervals can lead to incorrect conclusions about treatment effects.
Sources